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Abstract:  Background: Malaria 
remains a major cause of morbid-
ity and mortality, thus there is 
need for quick, reliable inexpen-
sive diagnostic tool to facilitate its 
prompt treatment especially in 
resource poor settings. 
Objectives: To compare the sensi-
tivity of a locally available His-
tidinerich protein-2 based rapid 
diagnostic test (RDT) with the 
standard microscopy. 
Methods: This study was carried 
out to test the performance of an 
histidine rich protein -2 rapid di-
agnostic test (RDT) against the 
standard microscopy in the diag-
nosis of malaria among febrile 
under-five children attending 
Paediatric Clinic of NAUTH 
Nnewi.  A total of 200 children 
under the age of five years were 
recruited for the study. Data on 
socio-demographic characteristics 
and symptoms were collected 
through an interviewer adminis-
tered questionnaire. Blood sample 
was collected in EDTA bottle 
after observing universal precau-
tions. All of them were tested 
with both Giemsa stained blood 
smear and Histidine rich protein-2
(HRP-2) rapid diagnostic test 
(RDT).  
Results: There were 118 males and 
82 females, giving a male: female 
ratio of 1.44:1. Their ages ranged 
from 3-59 months and the average 
age was 27+17.49 months. Aver-
age number of days the subjects 
had fever before presentation were 
3.78+1.95 days with a range of 1-
14 days.   Body temperature 
ranged from 35.9-40.40C with av-
erage of 37.7+0.80C. Forty (20%) 
were positive by microscopy while 
42 (21%) were positive by rapid 
diagnostic test. Twenty-percent of 
those positive by microscopy 
(n=8) were negative by RDT while 
23.8% of those positive by RDT 
(n=10) were negative by micros-
copy. Using microscopy as a gold 
standard, the sensitivity of the 
RDT was 80%, the specificity was 
93.8%. The positive and negative 
predictive values were 76.2% and 
94.9% respectively.  
Conclusion: Based on these find-
ings, the RDT demonstrated  rea-
sonable concordance with micros-
copy and was recommended for 
use at every level of healthcare in 
the diagnosis of malaria. 
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Introduction 
 
Malaria is an acute infectious disease caused by proto-
zoa, Plasmodium and transmitted by the bite of an in-
fected female Anopheles mosquito, the vector. It is an 
important parasitic disease in humans, especially in the 
tropics and subtropics, with the potential of causing very 
severe or fatal illness in children and adults. Most worri-
some are the consequences amongst children under the 
age of five years, in whom it constitutes a major cause 
of morbidity and mortality1,2. Pregnant women and non-
immune subjects are also significantly vulnerable to the 
severe and potentially fatal forms of the disease1,2. In 
Nigeria the prevalence of malaria is high, and it is one of 
the leading causes of morbidity and mortality in the 
country, accounting for 25% of infant mortality and 
30% of childhood mortality2-4.  Yet, the vast majority of 
infections are not identified due to problems bordering 
mainly on laboratory diagnosis, and except the diagnosis 
of malaria is given the desired priority, the battle for 
control of malaria in the developing countries may  
remain insurmountable. 
 
The Roll Back Malaria initiative emphasizes prompt and 
accurate diagnosis of malaria as the key to effectiv  
management of this childhood scourge5. Clinical diagno-
sis of malaria is imprecise, but remains the basis for 
therapeutic care for the vast majority of febrile patients 
in malaria endemic areas, where most of the time, labo-
ratory diagnosis is out of reach. Despite this obvius 
need for improvement, malaria diagnosis is the most 
neglected aspect of malaria research accounting for less 
than 0.25% of the 323 million dollars invested in ma-
laria research, in 20046. Yet, rational therapy of malaria 
requires a diagnostic tool with “decent” sensitivity and 
specificity values, thus preventing wastage of treatment 
cost.  
 
Confirmatory diagnosis before initiation of treatment in 
recent times regained attention, a trend that was some-
what influenced by the spread of drug resistance and 
thus the requirement of more expensive drugs7. Micro-
scopic examination of Giemsa stained blood smear has 
always been the gold standard of malaria diagnosis. It i  
a very suitable instrument for malaria diagnosis and con-
trol, because it is inexpensive to perform, capable of 
differentiating between the malaria species and indeed, 
in quantifying parasite density. However, it is encum-
bered by the fact that it requires a well trained an com-
petent microscopist, rigorous maintenance of functio al 
infrastructure plus effective quality control and quality 
assurance, in addition to regular power supply. Theim-
port of the potential limitation posed by poor expertis  is 
clearly worse in the developing countries but even in 
developed countries, expert microscopists are scarce.  
  
A  malaria rapid diagnostic test (MRDT) is a device that 
promptly detects malaria antigen in a small amount of 
blood (about one drop) by immunochromatographic 
assay with monoclonal antibodies directed against the 
parasite antigen and impregnated on a test strip.8The 
result is usually a coloured test line and this is obtain-
able in 5-20 minutes. It does not need sophisticated 
training, manpower or electricity. It can therefore b  
used in both urban and rural areas especially where ex-
pert microscopist is scarce. Plasmodium falciparum is 
the predominant cause of malaria in West African sub- 
region9. It is the only specie of Plasmodium the pro-
duces Histidine rich protein-2, the enzyme detected by  
most available MRDT. 
This study is aimed at comparing the sensitivity of lo-
cally available and approved Histidine rich protein-2 
based MRDT with microscopy (gold standard), to ascer-
tain and validate its usefulness in the diagnosis of ma-






Materials and method 
 
The study was carried out at the children’s out-patient 
clinic and Children’s Emergency room of Nnamdi 
Azikiwe University Teaching Hospital (NAUTH) 
Nnewi, Nigeria. The hospital provides a wide range of 
medical, surgical, diagnostic, out-patient, in-patien , 
rehabilitative and support services. The hospital min-
tains a Paediatric out-patients’ clinic and a childrens’ 
emergency room services every day.  
 
Nnewi is a commercial city located in Nnewi North  
Local Government Area of Anambra state, South-East, 
Nigeria. Its population based on 2006 census estimate is 
391,227. The people are predominantly Igbo-speaking 
and mainly traders and civil servants. Nnewi is located 
on latitude 60 01’ N and longitude 60 55’E, has a mean 
daily temperature of 30.4oC, and mean annual rainfall of 
about 200 cm.10 It has two main seasonal variations; the 
rainy season which spans between April and November 
and the dry season which lasts from November to March 
each year. Nnamdi Azikiwe University Teaching Hospi-
tal is a tertiary institution in the State and enjoys huge 
patronage and referrals of patients from all over  
Anambra State and neighbouring states. 
 The study is a Cross–sectional, hospital based observa-
tional study done during the months of May and June 
2012. Malaria antigen detected with HRP-2 based RDT 
(SD bioline) was compared with microscopy results.   
This study involved children aged 0-59 months   attend-
ing the children’s out-patient clinic and children’s emer-
gency room of the Nnamdi Azikiwe University Teach-
ing Hospital Nnewi, presenting with  fever defined as
axillary temperature of ≥ 37.5°C (measured with mer-
cury in glass thermometer), or history of fever within the 
last 72 hours. 
 
Institutional ethical approval was obtained from the  
Ethics Committee of the Nnamdi Azikiwe University 
Teaching Hospital Nnewi. All the subjects for this study 
who met the inclusion criteria were recruited as they 
presented at the Children’s Outpatients’ Clinic or the 
Children’s Emergency Room of the hospital. They were 
recruited consecutively until the sample size was met. 
 
The data on socio-demographic information as well as 
symptoms were collected via a questionnaire which was
administered to the mother or the caregiver. About 2mls 
of blood was collected from each participant and put in 
an ethylene diamine tetracetic acid (EDTA) bottle; asep-
tic and universal safety precautions were maintained all 
through. The RDTs were performed by the researcher 
according to manufacturer’s instruction.  The thick and 
thin blood smear were prepared using  3% Giemsa stain
according to standard WHO recommendations11. The 
slides were prepared and read by a laboratory scientist 
who is certified by the World Health Organization  The 
RDTs and microscopy were performed independent of 
each other and were brought together at the collatin 
stage. The RDT kits were supplied by the manufacturer, 
SD Bioline, (Standard Diagnostic Incorporated, Alten-
hostrasse, 80D-66386 St Ingbert, Germany) through 
60 
their marketer in Nigeria (Codis pharma limited, 15 Fa-
tai Irawo Street, off Airport Road, Ajao Estate, Lagos, 
Nigeria  Batch No 082112).  Quality was assured by 
keeping the test kits within the temperature range of 
250C-280C which is within the limit recommended by 
the manufacturers throughout the period of the study. 
Data was analyzed using computer software SPSS 
(version-16 Chicago, IL). The relevant means, standard 
deviations and percentages were calculated.      
Relative usefulness of the RDTs was determined using 
sensitivity, specificity, positive predictive and negative 
predictive values. 
The well known malaria parasite (MP) detection using 







A total of 200 children under the age of five years were 
recruited for the study. There were 118 males and 82 
females, giving a male: female ratio of 1.44:1. Their 
ages ranged from 3-59 months and the mean age was 
27+17.49 months. Those in the age range of 12-23 
months and 24-35months constituted the highest number 
(23%) each (Table 1).  
 










The mean number of days the subjects had fever befoe 
presentation were 3.7+1.9 days with a range of 1-14 
days. Body temperature ranged from 35.9-40.40C with 
mean of 37.7+0.80C. Fourty (20%) were positive by 
microscopy, while 42 (21%) were positive by rapid d-
agnostic test (figure1). Twenty percent of those positive 
by microscopy (n=8) were negative by RDT, while 
23.8% of those positive by RDT (n=10) were negative 
by microscopy. Table 2 Shows the evaluation of accu-
racy of RDT in the diagnosis of malaria using micros-
copy as a gold standard. 
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Table 2: Evaluation of accuracy of RDT in the diagnosis of      







• Sensitivity  =80.0%                           
• Positive predictive value =76.2%    
• False positive rate = 6.2%                
• Specificity = 93.8% 
• Negative predictive value =94.9% 
• False negative rate =20.0% 
Note; Sensitivity = True positive/true positive + false negative  x 
(100);  Specificity = True negative /True negative + false positive x 
(100) ; Positive predictive Value = True positive/ true positive + false 
positive x (100); Negative predictive value= True negative/ true nega-
tive +false negative 
 
Using microscopy as a gold standard, the sensitivity of 
the RDT was 80%, the specificity was 93.8%, while th
positive and negative predictive values were 76.2% and
94.9%respectively. False positive was 6.2% while fase 
negative was 20%.The 20% of the subjects which con-
stitute the false positives had a mean parasite density of 
731/µL, while the true positive subjects had a mean 
parasite density of 23,179/µL.   
Parasite density ranged from 40-136000/µL with a men 
of 18,689/µL. Those in the age range of 0-11 months 
had the highest parasite density with a mean of 38,144/
µL, whereas those in the age range of 12-23 months had 
the least parasite density with a mean 721/µL .  At a 
density of >3350 parasites/µL, sensitivity was 100%, at 
>2000 parasites /µL sensitivity of the RDT was 89.4%, 
and 62% at <500 parasites/µL. However at a density of 
100 parasites/µL and below sensitivity was 0%.  
(Table 3). 
 
Table 3: The frequency distribution of malaria status and sen-






This study established a high level of concordance  
between the rapid diagnostic test kit (SD Bioline) used 




















and RDT Test Result 




Parasite Density < 100 
Positive 
Negative 
Parasite Density ≤ 500 
Positive 
Negative 
Parasite Density >2000 
Positive 
Negative 




























was fairly reasonable while the specificity of 93.8% was 
significantly high. The implication is that at a sen itivity 
of 80% the kit is capable of detecting 80 out of 100 chil-
dren with malaria, i.e. it will miss 20% of the popula-
tion. Specificity is the ability of the kit to detect false 
positives implying that the kit has the ability to detect 93 
out of every 100 children who do not have malaria. Al-
though these figures are less than the 95% recommended 
by the World Health Organization (WHO), and though 
microscopy is the gold standard there is still possibility 
of human error and technical problem of microscopic 
identification of parasites which could explain this dis-
parity. Even among expert microscopists, ability 
vary12,13. Another possibility is the fact that those  
children who may have received some anti-malaria be-
fore presentation were not excluded in this study, and
HRP-2 is known to persist in the blood for a few weeks 
after treatment. Thus the test may still remain positive 
even when the parasites have been cleared.  
 
The positive predictive value of 76.2% means that te 
kit has the capability of confirming malaria with a preci-
sion of 76%, while the negative predictive value of 
94.9% means that the RDT is good in ruling out malari , 
thus giving the clinician the confidence that a negative 
test excluded malaria in about 95% of cases. Althoug  
the false positive rate of 6.2% is low enough to be ac-
cepted, the false negative rate of 20% is on the high side. 
Several factors such as low parasite density14, could be 
an explanation for this. But in the present study, the sub-
jects that constitute this 20% false negative have a mean 
parasite density of 731parasites/microlitre which is quite 
low compared to the mean density of 23,719 parasites/
microlitre of the true positive subjects. Other factors 
such as deletion or mutation of HRP-2 gene15 have been 
reported in some cases as reasons. It has also been sug-
gested that anti-HRP-2 antibodies in humans may ex-
plain some false negative tests16. The sensitivity and 
specificity findings in this study are similar to the find-
ings (82% and 91%) by Adesanmi et al17  in a similar 
study using HRP-2 based RDT among febrile children in 
Enugu South-East Nigeria. The positive and negative 
predictive values documented in this study were also 
similar to Adesanmi’s17 findings.  Sani et al18 using an 
HRP-2 based RDT in Sokoto documented a sensitivity 
of 90.2% which is higher than the 80% in the present 
study.  It is possible that the older age group (0-12years) 
involved in Sani’s18 study may have contributed to this 
disparity because in endemic areas older children with
malaria  are likely not to be symptomatic until much 
higher parasite densities are reached than younger  
children who are less immune to malaria. They however, 
documented a specificity of 95.4% which is similar to 
the 93.8% documented in the present study. Ly and  
co-workers19 in Senegal documented sensitivity and 
specificity of 100% and 98.3% for an HRP-2 based 
RDT. They also documented positive and negative pre-
dictive values of 80% and 100% respectively which are 
little higher than those of the present study, The sensitiv-
ity, specificity and predictive values documented in this 
study is also similar to a study done in India20 nd  other 
studies elsewhere21,22, 
 
The sensitivity of RDT is usually affected by parasite 
density and this study is not an exception.  The sensitiv-
ity of the RDT in the study was noted to be reduced by 
low parasite density;  it was 100% at a density of>3335 
parasites/microlitre, 89.4% at >2000 and 62%  at  <500 
parasites/microlitre. (Table 3)  This is similar to the 
findings in other studies.18,23Sani et al18 similarly docu-
mented that at a density of >1600 parasites/microlitre 
sensitivity was 100% while it was 62% at a density of 
<800 parasites/microlitre. In the evaluation of an HRP-2 
prototype assay in Thailand and Peru for P. falciparum, 
sensitivity was found to be 100% for parasite density 
≥500/µL and 83% for <500/µL24. The sensitivity of this 
kit was however noted to drop to 0% at parasite density 
of 100/microlitre and below. Although this agrees with 
the recommendation by WHO, the implication is that t e 
kit is not able to detect malaria parasites at such a low 
density. But even at such low density, children particu-
larly infants may still manifest with symptoms of ma-
laria25 and relating to this study means that SD bioline 
will fail to detect Plasmodium falciparum at density 
<100/µL. This might result in missing some cases of 
malaria in children especially infants, which could be 
fatal. However it must be noted that it is only three sub-
jects, representing 7.5 percent of the positive subjects 





Malaria rapid diagnostic test in this study demonstrated 
a reasonable concordance with microscopy, having 
achieved a sensitivity of 80% and specificity of 93.8%. 
It is therefore recommended for use at every level of 
healthcare delivery, but result must be interpreted with 
caution since it may not detect malaria in 20% of  
infected persons. 
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